Immune-mediated necrotizing myopathy: clinical features and pathogenesis
Y Allenbach, O Benveniste, W Stenzel… - Nature Reviews …, 2020 - nature.com
Immune-mediated necrotizing myopathy (IMNM) is a group of inflammatory myopathies that
was distinguished from polymyositis in 2004. Most IMNMs are associated with anti-signal …
was distinguished from polymyositis in 2004. Most IMNMs are associated with anti-signal …
Statin-associated autoimmune myopathy
AL Mammen - New England Journal of Medicine, 2016 - Mass Medical Soc
Statin-Associated Autoimmune Myopathy | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 …
Y Allenbach, AL Mammen, O Benveniste… - Neuromuscular …, 2018 - Elsevier
Among the idiopathic inflammatory myopathies (IIMs), immune-mediated necrotizing
myopathies (IMNMs) have been identified as important and separate entities during the past …
myopathies (IMNMs) have been identified as important and separate entities during the past …
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy
Objective To elucidate the common and distinct clinical features of immune-mediated
necrotising myopathy (IMNM), also known as necrotising autoimmune myopathy associated …
necrotising myopathy (IMNM), also known as necrotising autoimmune myopathy associated …
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group Update (2016)
GBJ Mancini, S Baker, J Bergeron, D Fitchett… - Canadian Journal of …, 2016 - Elsevier
Abstract The Canadian Consensus Working Group has updated its evaluation of the
literature pertaining to statin intolerance and adverse effects. This overview introduces a …
literature pertaining to statin intolerance and adverse effects. This overview introduces a …
[HTML][HTML] Autoantibodies associated with connective tissue diseases: what meaning for clinicians?
K Didier, L Bolko, D Giusti, S Toquet… - Frontiers in …, 2018 - frontiersin.org
Connective tissue diseases (CTDs) such as systemic lupus erythematosus, systemic
sclerosis, myositis, Sjögren's syndrome, and rheumatoid arthritis are systemic diseases …
sclerosis, myositis, Sjögren's syndrome, and rheumatoid arthritis are systemic diseases …
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy
E Tiniakou, I Pinal-Fernandez, TE Lloyd… - …, 2017 - academic.oup.com
Objective. To study disease severity and response to therapy in a large cohort of patients
with anti-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR)-associated myositis …
with anti-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR)-associated myositis …
Idiopathic inflammatory myopathies: a review
C Ashton, S Paramalingam, B Stevenson… - Internal Medicine …, 2021 - Wiley Online Library
Idiopathic inflammatory myopathy (IIM) is the umbrella term including dermatomyositis (DM),
polymyositis (PM), overlap myositis (OM), sporadic inclusion body myositis (IBM) and …
polymyositis (PM), overlap myositis (OM), sporadic inclusion body myositis (IBM) and …
Epidemiology of the idiopathic inflammatory myopathies
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic
autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints …
autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints …
Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy
Immune checkpoint inhibitors have revolutionized the landscape of cancer treatment.
Alongside their many advantages, they elicit immune-related adverse events, including …
Alongside their many advantages, they elicit immune-related adverse events, including …